Monday, Nov. 25, 2024

AdvertiseDonateSubmit
NewsSportsArtsOpinionThe QuadPhotoVideoIllustrationsCartoonsGraphicsThe StackPRIMEEnterpriseInteractivesPodcastsClassifieds

IN THE NEWS:

LIVE: Coverage of the Christopher Rodriguez trialNative American History Month 2024
Hedy Wang | Enterprise editor
Wang is the Enterprise editor. She was the News editor last year and an assistant News editor for the Features & Student Life beat the year before that. She is a fourth-year economics and communications student.
Wang is the Enterprise editor. She was the News editor last year and an assistant News editor for the Features & Student Life beat the year before that. She is a fourth-year economics and communications student.

Opinion

June 10, 2020 6:18 p.m.

The newsroom pushed me to rise to the occasion and overcome self-doubt -30-

Early in my tenure as an assistant News editor, my top editor at the time thought I was the most likely out of our entire team to quit.

By Hedy Wang

International

Aug. 11, 2019 11:22 p.m.

Hong Kong is now a city of protests and tear gas, a city indomitable in its ideals

I was on a two-week trip to visit family in Taiwan when I decided to make an impromptu visit to Hong Kong during its eighth week of political unrest.

By Hedy Wang

News

Oct. 19, 2018 1:42 a.m.

Regenerative medicine institute awards $5 million grant to UCLA retinal researchers

UCLA researchers received $5 million to further research on stem-cell based therapies for eye conditions that result in blindness.
The California Institute for Regenerative Medicine awarded the grant to researchers in the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute, who have been working to develop a treatment that will generate retinal cells typically lost in blinding eye diseases using stem cells derived from patients’ own skin cells, a university press release announced Thursday.

By Hedy Wang

searching for more articles...

Featured Classifieds
More classifieds »